| First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised … YY Janjigian, K Shitara, M Moehler, M Garrido, P Salman, L Shen, ... The Lancet 398 (10294), 27-40, 2021 | 1559 | 2021 |
| Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer K Shitara, JA Ajani, M Moehler, M Garrido, C Gallardo, L Shen, ... Nature 603 (7903), 942-948, 2022 | 215 | 2022 |
| Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer: Epigenetic control of the RUNX2 P1 promoter AM Herreño, AC Ramírez, VP Chaparro, MJ Fernandez, A Cañas, ... Tumor Biology 41 (5), 1010428319851014, 2019 | 34 | 2019 |
| Malignant solitary fibrous tumor of the kidney: report of the first case managed with interferon J Cuello, R Brugés Case Reports in Oncological Medicine 2013, 2013 | 24 | 2013 |
| Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/oesophageal adenocarcinoma (CheckMate 649 … YY Janjigian, K Shitara, M Moehler, M Garrido, P Salman, L Shen, ... Lancet (London, England) 398 (10294), 27, 2021 | 17 | 2021 |
| Impact of COVID-19 infection on patients with cancer: experience in a Latin American country: the ACHOCC-19 study AV Ospina, R Bruges, W Mantilla, I Triana, P Ramos, S Aruachan, ... The Oncologist 26 (10), e1761-e1773, 2021 | 13 | 2021 |
| Características de los pacientes con cáncer de pulmón de célula no pequeña en el Instituto Nacional de Cancerología de Colombia ML Alarcón, R Bruges, C Carvajal, C Vallejo, R Beltrán Revista Colombiana de Cancerología 25 (2), 103-109, 2021 | 9 | 2021 |
| Hyperprogression in pediatric melanoma metastatic to the breast treated with a checkpoint inhibitor LB Vaca, SD Mendoza, JC Vergel, X Rueda, R Bruges, SM Díaz, ... Cureus 11 (1), 2019 | 9 | 2019 |
| Regulación epigenética en cáncer de pulmón: implicaciones para el clínico APR Moreno, RE Bruges, AC Arboleda, LFJ García Universitas Médica 57 (3), 332-347, 2016 | 8 | 2016 |
| Low Prevalence of the Four Common Colombian Founder Mutations in BRCA1 and BRCA2 in Early‐Onset and Familial Afro‐Colombian Patients with Breast Cancer E Vargas, DM Torres Lopez, R Deugd, F Gil, A Nova, L Mora, LF Viaña, ... The oncologist 24 (7), e475-e479, 2019 | 6 | 2019 |
| Two unusual mutations in the epidermal growth factor receptor gene in a patient with lung adenocarcinoma MZ Laguado, A Zuluaga, RP Medina, R Bruges Cureus 14 (2), 2022 | 5 | 2022 |
| Supervivencia en adenocarcinoma gástrico posterior a tratamiento adyuvante tratados en el Instituto Nacional de Cancerología de Colombia durante el 2009 F Grosso, R Brugés, L Villamizar Revista Colombiana de Cancerología 17 (2), 55-61, 2013 | 5 | 2013 |
| Mieloptisis: Viejos aspectos, nuevos conceptos M Luján, AF Cardona, A Yepes, E Carrasco, L Revéiz, R Brugés, ... Acta Médica Colombiana 34 (4), 169-175, 2009 | 5 | 2009 |
| Neoadyuvancia en cáncer de mama R Brugés, LH Guzmán, O Sánchez, S Díaz, É Vergara Revista Colombiana de Cancerología 13 (3), 157-174, 2009 | 5 | 2009 |
| Adult Wilms' tumor: case report and literature review CV Yepes, M Bermudez, D Camacho-Nieto, J Mesa, R Bruges Cureus 13 (6), 2021 | 4 | 2021 |
| Tumor-to-tumor metastasis: lung adenocarcinoma as a recipient of metastasis from renal cell carcinoma: a case report D Caballero, C Vallejo, HR Osma, R Brugés, H Garcia, CAC Fierro, ... The American Journal of Case Reports 22, e932012-1, 2021 | 4 | 2021 |
| Hiponatremia luego de uso de cisplatino: a propósito de un caso A Ovalle, D González, C Bonilla, R Brugés, C Rúa Marín Revista Colombiana de Cancerología 20 (3), 135-140, 2016 | 3 | 2016 |
| Peripheral neural sheath breast sarcoma: case report and literature review YJ Forero, MI Zapata Laguado, X Briceño, RE Brugés, F Contreras Case Reports in Oncology 15 (1), 403-412, 2022 | 2 | 2022 |
| Impact of COVID-19 infection on cancer patients experience in Latin American country, ACHOCC-19 Study AV Ospina, R Bruges, W Mantilla, I Triana, P Ramos, S Aruachan Oncologist, 2021 | 2 | 2021 |
| Tratamiento de cáncer de pulmón metastásico (estadio IV) de célula no pequeña: consenso de expertos, Asociación Colombiana de Hematología y Oncología (ACHO). AV Ospina, R Brugés, M Lema, G de Lima Lopes Jr, R Gómez, ... Revista Colombiana de Hematología y Oncología 5 (1), 61-71, 2018 | 2 | 2018 |
